18F-mFBG Cardiac Uptake With Lewy Body Dementia

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions

Parkinson Disease (PD)Lewy Body Dementia (LBD)

Interventions

DRUG

18F-MFBG

Intravenous injection of 222-370 MBq (6-10 mCi) 18F-mFBG followed by whole body PET imaging.

All Listed Sponsors

lead

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

INDUSTRY

NCT07176286 - 18F-mFBG Cardiac Uptake With Lewy Body Dementia | Biotech Hunter | Biotech Hunter